Published in Medical Device Business Week, January 12th, 2004
Prevnar, also known as PCV7, is used to protect children against invasive pneumococcal disease, which can lead to meningitis or bloodstream infections.
A 1-week production stoppage in November month to improve the process that fills vials with vaccine has caused a ripple effect that may lead to delays in the shipping of Prevnar early in 2004, said Doug Petkus, spokesman for Collegeville, Pennsylvania-based drug maker Wyeth Pharmaceuticals.
"That type of stoppage tends to create bottlenecks in our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.